Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-17-061621

EVP & Chief Strategy Officer sold 7,000 shares at $15.00 ($105,000)

  • EVP & Chief Strategy Officer acquired 4,146 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Soffer Gad EVP & Chief Strategy Officer 2017-11-15 Option exercise +4,146 263,236 D: show line 1 in the form
Soffer Gad EVP & Chief Strategy Officer 2017-11-17 Sale −7,000 $15.00 $105,000 256,236 D: show line 2 in the form
Open-market sales · 7,000 sh · avg $15.00 · $105,000

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Soffer Gad EVP & Chief Strategy Officer 2017-11-15 Option exercise · Restricted Stock Units −4,146 2,764 D: show line 3 in the form
Loading xslF345X03/doc4.xml…